119 related articles for article (PubMed ID: 22782421)
1. Influenza pandemics--pregnancy, pathogenesis, and perinatal outcomes.
Steinhoff MC; MacDonald NE
JAMA; 2012 Jul; 308(2):184-5. PubMed ID: 22782421
[No Abstract] [Full Text] [Related]
2. H1N1 influenza vaccination during pregnancy.
Fell DB; Dodds L; McNeil S; MacDonald NE
BMJ; 2014 May; 348():g3500. PubMed ID: 24874846
[No Abstract] [Full Text] [Related]
3. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
Pasternak B; Svanström H; Mølgaard-Nielsen D; Krause TG; Emborg HD; Melbye M; Hviid A
JAMA; 2012 Jul; 308(2):165-74. PubMed ID: 22782418
[TBL] [Abstract][Full Text] [Related]
4. Pandemic vaccines and small excess of Guillain-Barre cases.
BMJ; 2013 Mar; 346():f1714. PubMed ID: 23516147
[No Abstract] [Full Text] [Related]
5. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study.
Trotta F; Da Cas R; Spila Alegiani S; Gramegna M; Venegoni M; Zocchetti C; Traversa G
BMJ; 2014 May; 348():g3361. PubMed ID: 24874845
[TBL] [Abstract][Full Text] [Related]
6. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccine and Guillain-Barré syndrome: making informed decisions.
Poland GA; Poland CM; Howe CL
Lancet; 2013 Apr; 381(9876):1437-9. PubMed ID: 23622271
[No Abstract] [Full Text] [Related]
8. Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines.
DeStefano F; Vellozzi C; Schonberger LB; Chen RT
BMJ; 2011 Jul; 343():d4159. PubMed ID: 21750073
[No Abstract] [Full Text] [Related]
9. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.
Verity C; Stellitano L; Winstone AM; Andrews N; Stowe J; Miller E
Lancet; 2011 Oct; 378(9802):1545-6. PubMed ID: 22035553
[No Abstract] [Full Text] [Related]
10. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
[TBL] [Abstract][Full Text] [Related]
11. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
[TBL] [Abstract][Full Text] [Related]
12. The self-controlled case series method for evaluating safety of vaccines.
Hawken S; Wilson KR
Med J Aust; 2012 Nov; 197(10):578-9. PubMed ID: 23163690
[TBL] [Abstract][Full Text] [Related]
13. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
Press R; Andersen O
Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
[No Abstract] [Full Text] [Related]
14. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
[TBL] [Abstract][Full Text] [Related]
15. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
[TBL] [Abstract][Full Text] [Related]
16. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.
Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E
Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755
[TBL] [Abstract][Full Text] [Related]
17. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
[TBL] [Abstract][Full Text] [Related]
18. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G
JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419
[TBL] [Abstract][Full Text] [Related]
19. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing.
Wu J; Xu F; Lu L; Lu M; Miao L; Gao T; Ji W; Suo L; Liu D; Ma R; Yu R; Zhangzhu J; Liu W; Zeng Y; Li X; Zhang X; Pang X; Deng Y
N Engl J Med; 2010 Dec; 363(25):2416-23. PubMed ID: 21158658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]